St. Jude's next-gen heart defibrillators gain CE mark

05/10/2013 | RTT News

St. Jude Medical has earned the CE mark in Europe to market its Ellipse and SJM Assura implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The devices automatically adjust voltage in the event of an electrical short and help reduce risk for lead abrasion.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC